Effingham Equity – FDA 483, Jan 31, 2022

Effingham Equity, a medicated feed manufacturer in Effingham, IL, was cited for significant deficiencies in its hazard analysis and preventive controls for animal food safety. The inspection revealed failures to adequately control mycotoxins like aflatoxin and fumonisin in incoming ingredients, leading to contaminated livestock feed. Additionally, the firm failed to properly evaluate various hazards and lacked adequate process controls and drug identification procedures in its mixing areas.